The value of targeting recombination as a strategy against coronavirus diseases.

Santiago, Enrique; Caballero, Armando

Santiago, Enrique; Caballero, Armando.

Santiago E; Departamento de Biología Funcional, Facultad de Biología, Universidad de Oviedo, Oviedo, Spain. esr@uniovi.es.
Caballero A; Centro de Investigación Mariña, Departamento de Bioquímica, Genética e Inmunología, Edificio CC Experimentais, Campus de Vigo, As Lagoas, Universidade de Vigo, Marcosende, 36310, Vigo, Spain.

Heredity (Edinb) ; 125(4): 169-172, 2020 10.

Article in English | MEDLINE | ID: covidwho-628855

Subject(s)

Antiviral Agents/therapeutic use; Coronavirus Infections/drug therapy; Coronavirus/genetics; Recombination, Genetic/drug effects; Antiviral Agents/pharmacology; Coinfection/prevention & control; Coinfection/virology; Coronavirus/drug effects; Coronavirus Infections/virology; Genetic Fitness; Mutation; Virus Replication/drug effects; Virus Replication/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Recombination, Genetic / Coronavirus Infections / Coronavirus Language: English Journal: Heredity (Edinb) Year: 2020 Document Type: Article Affiliation country: S41437-020-0337-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google